Related Experiment Videos
Apoptosis of multiple myeloma
Marcela Oancea1, Aruna Mani, Mohamad A Hussein
1Department of Cancer Biology, Lerner Research Institute, Cleveland, Ohio 44195, USA.
International Journal of Hematology
|November 16, 2004
Summary
Multiple myeloma (MM) is a cancer where plasma cells accumulate due to failed apoptosis. Understanding apoptosis pathways is key to treating MM and overcoming treatment resistance.
Area of Science:
- Oncology
- Cell Biology
- Molecular Biology
Background:
- Multiple myeloma (MM) involves malignant plasma cells in the bone marrow.
- MM cell accumulation results from impaired apoptosis, a regulated cell death process.
- Resistance to apoptosis is crucial in MM pathogenesis and treatment failure.
Purpose of the Study:
- To review key concepts and recent studies on signaling pathways in MM.
- To summarize the clinical significance of these pathways in MM.
Main Methods:
- Review of scientific literature on MM, apoptosis, and signaling pathways.
- Focus on extrinsic and intrinsic apoptosis pathways and their regulation.
- Analysis of therapeutic modalities targeting apoptosis-related proteins in MM.
Main Results:
- Apoptosis is executed via death receptor (extrinsic) and mitochondrial (intrinsic) pathways.
- Mitochondria are central to the intrinsic pathway, targeted by radiation and chemotherapy.
- MM therapies modulate Bcl-2 family proteins and apoptosis inhibitors, regulated by p53, NF-κB, and STAT factors.
Conclusions:
- Dysregulation of apoptosis is central to multiple myeloma development and treatment resistance.
- Targeting apoptosis signaling pathways offers therapeutic strategies for MM.
- Further research into these pathways can improve clinical outcomes for MM patients.